本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Repare Therapeutics Inc.

1.50
-0.0600-3.85%
盘后1.500.00000.00%17:04 EDT
成交量:7.90万
成交额:11.87万
市值:6,433.71万
市盈率:-0.50
高:1.58
开:1.58
低:1.43
收:1.56
数据加载中...
2021/08/12

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/08/12

重要事件披露

8-K - Current report
2021/07/21

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/05/25

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/05/14

重要事件披露

8-K - Current report
2021/05/13

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/13

重要事件披露

8-K - Current report
2021/04/08

重要事件披露

8-K - Current report
2021/04/06

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/03/23

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/03/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/03/04

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/04

重要事件披露

8-K - Current report
2021/03/02

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/26

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/02/16

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/08

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/01/25

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/11/12

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]